Melanocytic Nevus · What Is It, Causes, Signs and Symptoms, and More

Published: Mar 27, 2026

Author: Anna Hernández, MD•

Editor: Alyssa Haag•

Editor: Emily Miao, PharmD•

Editor: Kelsey LaFayette, DNP, ARNP, FNP-C•

Editor: Lily Guo•

Editor: Mary Roberts, MSN, RN•

Editor: Arianna Succi, MD

Illustrator: Jessica Reynolds, MS

7-day free trial

Go deeper with Osmosis

Osmosis is a learning platform with videos, questions, and AI tools to help you master topics like this.

4.8 · 12,000+ reviews

Watch quick, visual videos

Practice with Qbank-style questions

Use AI to explain, quiz, and review

Study anytime with the mobile app

Start free trial

No credit card · Cancel anytime

What is a melanocytic nevus?

A melanocytic nevus, more commonly known as a mole, is a dark spot on the skin that can vary in size and is caused by benign proliferations of pigment-producing cells called melanocytes. Most individuals with light skin tones have 20 to 30 melanocytic nevi on their body by the time they reach adulthood. These moles are typically harmless; however, individuals with a high number of nevi, atypical or dysplastic nevi, and a family history of melanoma have an increased risk of developing melanoma, a type of skin cancer that affects melanocytes.

Learn deeper with Osmosis

Master this topic faster with videos, questions, and AI.

Used by 8M+ healthcare learners.

Start free trial

No credit card · Cancel anytime

What causes melanocytic nevi?

Melanocytic nevi are caused by benign proliferations of skin cells called melanocytes. These cells produce melanin, the pigment responsible for the color of the skin. Normally, melanocytes are distributed evenly throughout the basal layer of the epidermis, which is the outermost layer of the skin. Melanocytic nevi are formed when melanocytes proliferate, forming nests or clusters.

Melanocytic nevi can be classified as congenital or acquired. Congenital melanocytic nevi are typically present at birth or may appear within the first few months of life. On the other hand, acquired nevi appear throughout life due to predisposing factors like genetics, sun exposure, and skin type, with higher nevus counts seen in individuals with lighter skin tones. Individuals who are immunosuppressed and those with certain genodermatoses (a group of hereditary skin conditions) are at increased risk of developing acquired nevi.

What are the signs and symptoms of melanocytic nevi?

Melanocytic nevi can have different appearances based on their type, location, and the individual’s skin tone. Most congenital nevi are small (i.e., diameter less than 1.5 centimeters [cm]) or medium-sized (i.e., diameter between 1.5 cm and 20 cm). However, they can sometimes measure greater than 20 cm in diameter, and these are known as large, or giant, moles. Large congenital nevi carry the highest risk of melanoma transformation compared with smaller nevi. Congenital nevi range in color from tan to black or blueish, and the borders are often regular. A typical feature of congenital nevi is the presence of hair growth.

Acquired nevi, on the other hand, typically appear as brown, flat spots that may become raised over time and tend to be smaller than 6 millimeters (mm) in diameter (i.e., the size of a pencil eraser). They are usually symmetrical, with even borders, and consist of a single color. Acquired nevi are more common in sun-exposed areas, such as the trunk, arms, and lower legs, but they can appear anywhere on the body. Some acquired nevi have unique characteristics and are referred to by their names. For example, a Sutton or halo nevus is a mole surrounded by a round or oval halo that is lighter in color than the rest of the skin. The Spitz nevus is a dome-shaped pink, red, or brown mole that is more commonly found in children, particularly on the face and legs. A blue nevus is characterized by a blue coloration from the presence of melanocytes deep within the dermis.

What is an atypical nevus?

Atypical nevi are benign but have features overlapping with melanoma, including a size ≥5 mm, irregular borders, and variability in color. They often appear different from other moles on the same individual, which is referred to as the “ugly duckling” sign. While they are considered makers of increased melanoma risk – especially in individuals with many nevi or a family history of melanoma – the likelihood of transformation of any atypical nevus is low.

How are melanocytic nevi diagnosed?

Melanocytic nevi are diagnosed through clinical examination of the skin. Dermatologists may use a tool called a dermatoscope to help detect features that are not visible to the naked eye. This can assist in the clinical diagnosis and help differentiate common nevi from atypical nevi and malignant lesions such as melanoma. If the distinction is uncertain, nevi may be photographed to monitor any changes over time.

Individuals who have many moles or who have a family history of melanoma may be recommended to perform self-skin examinations at monthly intervals to spot any changes within existing moles or the development of new lesions.

A common method for identifying suspicious nevi is to use the ABCDE rule. ABCDE stands for asymmetry, border irregularities, color, diameter over 5 millimeters, and evolution, which refers to changes in size, color, or shape over time. The presence of one or more of these features indicates a higher chance of malignant transformation.

For a histopathologic diagnosis of suspicious nevi, a shave or punch biopsy may be performed.

How are melanocytic nevi treated?

Most melanocytic nevi remain benign throughout a person’s lifetime and require no treatment other than observation. However, several treatment options can help reduce the appearance of moles or remove them altogether in case of cosmetic concerns or concerning features.

Common treatment options include surgical removal such as shave excision, which involves “shaving” or removing the mole with a sharp blade. This technique is most appropriate in moles that affect only the epidermis. For deeper lesions, or in case of increased suspicion of malignancy, an excisional biopsy with narrow margins may be needed to remove the entire lesion. Laser therapy is rarely used for cosmetic treatment of clinically benign nevi after careful consideration. Lasers emit specific wavelengths of light that are absorbed by melanin and transformed into heat that destroys the pigment in the skin, decreasing the appearance of the mole. Lasers should not be used to treat suspicious lesions.

Some of the most effective ways to prevent the development of nevi include decreasing exposure to UV rays by wearing sun-protective clothing, using broad-spectrum sunscreen with a sun protection factor (SPF) of 30 or higher; and avoiding artificial UV rays like tanning beds. Studies have shown that these measures are especially effective during childhood and adolescence, which is when most melanocytic nevi are formed.

What are the most important facts to know about melanocytic nevi?

Melanocytic nevi or moles are small, dark spots on the skin that result from benign proliferation of pigment-producing cells called melanocytes. They can be present from birth or develop throughout one’s life. While melanocytic nevi are benign, having a large number of moles can be considered a risk factor for melanoma. Melanocytic nevi are diagnosed through skin examination. Dermatoscopes can be used to detect features that are not visible to the naked eye. The ABCDE rule (i.e., Asymmetry, Borders, Color, Diameter, and Evolution) is a mnemonic that can help individuals spot moles that may be atypical. Most melanocytic nevi do not require any treatment other than observation; however, they may be surgically removed if there is concern for atypia or treated with laser therapy if they are truly benign and are of cosmetic concern.

Key Takeaways

Definition	A melanocytic nevus, more commonly known as a mole, is a dark spot on the skin that can vary in size and is caused by benign proliferations of pigment-producing cells called melanocytes.
Causes/Risk Factors	Proliferation of melanocytes, forming nests or clusters. Can be: - Congenital - Acquired - Risk factors: - Sun exposure - Genetics - Skin type (lighter skin → higher risk) - Immunosuppression - Genodermatoses
Signs and Symptoms	- Congenital nevi: - Size: small (<1.5 cm), medium-sized (1.5-20 cm), large/giant (>20 cm) - Highest risk of melanoma transformation: large nevi - Color: from tan to black-blueish - Borders: often regular - Hair growth - Acquired nevi: - Brown, flat spots (may raise over time) - Size: usually <6 mm - Borders: even - More common in sun exposed-areas - Specific types exist (e.g., Sutton or halo nevus, Spitz nevus, blue nevus)
Atypical Nevus	- Benign nevi with overlapping features with melanoma - Size ≥5 mm, irregular borders, variability in color - “Ugly duckling sign”: often appear different from other moles
Diagnosis	- Clinical examination of the skin - Dermatoscope used by dermatologists for featuers invisible to naked eye - Sometimes photographed to monitor changes over time - For those with many moles/family history of melanoma: monthly self-skin examinations - ABCDE rule: asymmetry, border irregularities, color, diameter over 5 millimeters, and evolution - Biopsy for histopathological diagnosis of suspicious lesions
Treatment	- Observation - Removal (if concerning features or cosmetic concerns): - Surgical removal: - Shaving - Excisional biopsy with narrow margins (deeper lesions) - Laser therapy: for surely clinically benign lesions - Prevention: decrease exposure to UV rays (especially effective in childhood or adolescence) - Sun-protective clothing - Broad-spectrum sunscreen - Avoid artificial UV rays (e.g., tanning beds)

References

Camini L, Manzoni APD, Weber MB, Luzzato L, Soares AS, Bonamigo RR. Shave excision versus elliptical excision of nonpigmented intradermal melanocytic nevi: comparative assessment of recurrence and cosmetic outcomes. Dermatol Surg. 2021;47(2):e21-e25. doi:10.1097/DSS.0000000000002666

Frischhut N, Zelger B, Andre F, Zelger BG. The spectrum of melanocytic nevi and their clinical implications. J Dtsch Dermatol Ges. 2022;20(4):483-504. doi:10.1111/ddg.14776

Kiuru M, Tartar DM, Qi L, et al. Improving classification of melanocytic nevi: association of BRAF V600E expression with distinct histomorphologic features. J Am Acad Dermatol. 2018;79(2):221-229. doi:10.1016/j.jaad.2018.03.052

Mologousis MA, Tsai SYC, Tissera KA, Levin YS, Hawryluk EB. Updates in the management of congenital melanocytic nevi. Children (Basel). 2024;11(1):62. doi:10.3390/children11010062

Price HN, Schaffer JV. Congenital melanocytic nevi—when to worry and how to treat: facts and controversies. Clin Dermatol. 2010;28(3):293-302. doi:10.1016/j.clindermatol.2010.04.004

Sardana K, Chakravarty P, Goel K. Optimal management of common acquired melanocytic nevi (moles): current perspectives. Clin Cosmet Investig Dermatol. 2014;7:89-103. doi:10.2147/CCID.S57782